APA (7th ed.) Citation

Yamada, T., Nagasaka, T., Matsuhashi, N., Takahashi, T., Hirata, K., Nakamura, Y., . . . Yoshida, H. (2026). Clinical Impact of Baseline ctDNA RAS / BRAF Mutations on Conversion Surgery and Outcomes in First-Line Anti-EGFR Therapy for Advanced Colorectal Cancer. Cancers, 18(11), 1688. https://doi.org/10.3390/cancers18111688

Chicago Style (17th ed.) Citation

Yamada, Takeshi, et al. "Clinical Impact of Baseline CtDNA RAS / BRAF Mutations on Conversion Surgery and Outcomes in First-Line Anti-EGFR Therapy for Advanced Colorectal Cancer." Cancers 18, no. 11 (2026): 1688. https://doi.org/10.3390/cancers18111688.

MLA (9th ed.) Citation

Yamada, Takeshi, et al. "Clinical Impact of Baseline CtDNA RAS / BRAF Mutations on Conversion Surgery and Outcomes in First-Line Anti-EGFR Therapy for Advanced Colorectal Cancer." Cancers, vol. 18, no. 11, 2026, p. 1688, https://doi.org/10.3390/cancers18111688.